Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

7(100.0%)

7Total

N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05171231Completed

Performance and Safety of the Surgical Hemostatic Agent "HEMOCOLLAGENE®" in Patients Requiring Oral Surgery

Role: collaborator

NCT07385053Not ApplicableActive Not Recruiting

Real-Life Evaluation of the HA Dermal Filler ESTYME® LIFT

Role: lead

NCT07255261Not ApplicableRecruiting

Evaluation of Facial HA Dermal Fillers in Real-Life Conditions

Role: lead

NCT05776836Not ApplicableCompleted

Evaluation of HA Dermal Fillers in the Treatment of Pathological Facial Lipoatrophy

Role: lead

NCT05825170Not ApplicableRecruiting

Evaluation of a HA Dermal Filler in the Treatment of Lip Deformity

Role: lead

NCT06611098Not ApplicableRecruiting

New Treatment of Knee Osteoarthritis

Role: lead

NCT06097988Not ApplicableCompleted

Study on Knee Osteoarthritis

Role: lead

NCT02089490Not ApplicableUnknown

Evaluation of NEVELIA® in Terms of Safety and Efficacy for Third-degree Burns Treatment or Reconstructive Surgery

Role: lead

All 8 trials loaded